Handok (002390)

Seoul
28,800.00
+50.00(+0.17%)
  • Volume:
    38,714
  • Bid/Ask:
    28,750.00/28,800.00
  • Day's Range:
    28,550.00 - 29,000.00

002390 Overview

Prev. Close
28,750
Day's Range
28,550 - 29,000
Revenue
503.61B
Open
28,850
52 wk Range
22,850 - 44,500
EPS
1,957.22
Volume
38,714
Market Cap
395.7B
Dividend (Yield)
300.00 (1.04%)
Average Vol. (3m)
48,750
P/E Ratio
14.69
Beta
0.79
1-Year Change
19.5%
Shares Outstanding
13,763,533
Next Earnings Date
May 10, 2021
What is your sentiment on Handok?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyNeutralSellBuy
Technical IndicatorsSellStrong BuyBuyStrong SellBuy
SummaryNeutralStrong BuyNeutralStrong SellBuy

Handok Company Profile

Handok Company Profile

Industry
Major Drugs
Employees
883

HANDOK Inc. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company's products include Amaryl for diabetes; Tritace for hypertension, myocardial infarction, heart failure and other cardiovascular diseases; Teveten and Triapin for essential hypertension; Munobal for hypertension and stenocardia; Ketas for disturbance of cerebral circulation; Lasix for hypertension and edema, and remedies for skin and others. It also provides over-the-counter (OTC) pharmaceuticals, healthcare products, as well as medical devices, diagnostic reagents and vaccines. In addition, the Company is involved in the real estates rental business. On July 26, 2013, it changed its name to HANDOK Inc. from Handok Pharmaceuticals Co., LTD.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.